ArticleCell reports. Medicine2023

Tumor-immune microenvironment and NRF2 associate with clinical efficacy of PD-1 blockade combined with chemotherapy in lung squamous cell carcinoma.

Jianchun Duan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.